A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments. In this partnership, M2GEN will license its real-world data set (RWD) to Zephyr AI, while Zephyr AI will become a bioinformatics partner for M2GEN, providing the […]